Neogenomics Inc reports results for the quarter ended in December - Earnings Summary

NeoGenomics

21/02/2024 10:55

* Neogenomics Inc  NEO.OQ  reported quarterly adjusted
earnings of
3 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -6 cents.  The mean expectation of thirteen analysts for the
quarter was for a loss of 2 cents per share. Wall Street
expected results to range from -10 cents tozero cents per share.
    * Revenue rose 12.1% to $155.55 million from a year ago;
analysts
expected $152.54 million. 
    * Neogenomics Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The company reported a quarterly loss of $14.33 million.
    * Neogenomics Inc shares had fallen by 9.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 21.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Neogenomics
Inc
is $20.00 

This summary was machine generated from LSEG data February 21 at
10:55 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.02          0.03           Beat
 Sep. 30 2023      -0.07          0.00           Beat
 Jun. 30 2023      -0.11          -0.05          Beat
 Mar. 31 2023      -0.15          -0.09          Beat